Lista de obras - Klaus Schmierer - Dominio Público Uruguay

Association between pathological and MRI findings in multiple sclerosis

scientific article published on 01 February 2019

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

artículo científico publicado en 2013

B cells and multiple sclerosis spinal cord pathology

scientific article published on 14 April 2020

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS

scientific article published on 21 August 2020

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

scientific article published on 01 April 2018

Detecting and predicting neutralization of alemtuzumab responses in MS

scientific article published on 04 June 2020

Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine

artículo científico publicado en 2018

Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

scholarly article published in Journal of Neurology

Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis

scientific article published on 06 November 2019

Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme

artículo científico publicado en 2019

Inclusion criteria used in trials of people with progressive multiple sclerosis

artículo científico publicado en 2018

Magnetic resonance imaging correlates of neuro-axonal pathology in the MS spinal cord

scientific article published on 01 September 2018

Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis

artículo científico publicado en 2019

Potential mechanisms of action related to the efficacy and safety of cladribine

artículo científico publicado en 2019

Protecting people with multiple sclerosis through vaccination

artículo científico publicado en 2020

SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad

scientific article published on 08 May 2020

Synaptic loss in the multiple sclerosis spinal cord

artículo científico publicado en 2020

The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments

artículo científico publicado en 2020

The impact of smoking cessation on multiple sclerosis disease progression

scientific article published on 01 May 2022

The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis

artículo científico publicado en 2020

Towards a standard MRI protocol for multiple sclerosis across the UK

artículo científico publicado en 2019

Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis ⬇️

artículo científico publicado en 2019

Validating the portal population of the United Kingdom Multiple Sclerosis Register

scientific article published on 25 May 2018

Lista de obras de Klaus Schmierer

Association between pathological and MRI findings in multiple sclerosis

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

B cells and multiple sclerosis spinal cord pathology

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Detecting and predicting neutralization of alemtuzumab responses in MS

Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine

Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis

Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme

Inclusion criteria used in trials of people with progressive multiple sclerosis

Magnetic resonance imaging correlates of neuro-axonal pathology in the MS spinal cord

Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis

Potential mechanisms of action related to the efficacy and safety of cladribine

Protecting people with multiple sclerosis through vaccination

SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad

Synaptic loss in the multiple sclerosis spinal cord

The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments

The impact of smoking cessation on multiple sclerosis disease progression

The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis

Towards a standard MRI protocol for multiple sclerosis across the UK

Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis ⬇️

Validating the portal population of the United Kingdom Multiple Sclerosis Register